hepatitis B

GSK booth at AACR 2026

Biotech

GSK hep B drug cures one-fifth of patients in ‘major step’

After treatment with bepirovirsen, 19% of patients across two phase 3 trials achieved the strictly defined “functional cure” criteria for hep B.

Darren Incorvaia May 28, 2026 4:30am

alphabet blocks

Gilead turns down Assembly's ph. 1-stage HBV antiviral

Mar 20, 2026 5:14am

Bluejay

Mirum nets Bluejay and its ph. 3-stage hepatitis drug for $620M

Dec 8, 2025 9:45am

Layoffs

nChroma Bio sheds staff in research reorganization

Nov 12, 2025 5:31pm

Glowing puzzle piece fitting into puzzle

Arbutus regains China rights to potential hep B cure from Qilu

Jun 25, 2025 9:15am

hepatitis B virus

Vir won't advance potential hep B 'cure' without a partner

Feb 27, 2025 11:37am